Clinical trials recruiting for Breast Ductal Carcinoma In Situ
8
Recruiting trials
15
US states with sites
2
Countries
25%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Kansas | 3 |
| Ohio | 3 |
| Illinois | 2 |
| Michigan | 2 |
| Arizona | 1 |
| California | 1 |
| Florida | 1 |
| Massachusetts | 1 |
| Minnesota | 1 |
| Missouri | 1 |
| New York | 1 |
| Oregon | 1 |
Top cities
Kansas City, Kansas 3Ann Arbor, Michigan 2Chicago, Illinois 2Columbus, Ohio 2Boston, Massachusetts 1Buffalo, New York 1Charleston, South Carolina 1Cleveland, Ohio 1Duarte, California 1Houston, Texas 1
Self-screener
Recruiting trials
- A Novel Fluorescent Ductal Needle for Localization and Sampling of Micro Lesions in Breast Ducts
- A Patient Navigation Program for Addressing Disparities in Breast Cancer Care
- A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
- Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
- Identifying and Caring for Individuals With Inherited Cancer Syndrome
- Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
- Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
Related conditions
Trials recruiting for Breast Ductal Carcinoma In Situ often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Breast Carcinoma 74Breast Lobular Carcinoma In Situ 4Triple Negative Breast Carcinoma 10Malignant Solid Neoplasm 30Lynch Syndrome 28Invasive Breast Carcinoma 14Hematopoietic and Lymphoid System Neoplasm 4Estrogen Receptor-Positive Breast Carcinoma 5Colorectal cancer 1359
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Breast Ductal Carcinoma In Situ trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.